05:03 PM EST, 02/11/2025 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) reported its Q4 loss narrowed to $0.23 a share from the loss of $0.48 a year earlier.

Three analysts polled by FactSet expected a loss of $0.26.

Revenue in the three months ended Dec. 31 rose to $47.5 million from $45.8 million a year earlier, the company said Tuesday in a statement.

Analysts surveyed by FactSet expected $46 million.